Summary
In this study the efficacy and safety of short-term amlodipine administration on renal haemodynamics were evaluated in mild to moderate hypertensive subjects. Our final goal was to evaluate whether the reduced blood pressure induced by treatment was associated with maintenance of renal function.
After a run-in period with placebo, 30 hypertensive patients without cardiac or renal diseases were randomly allocated to a double-blind 4 weeks controlled study with amlodipine 10 mg once a day (15 patients) or placebo (15 patients).
Renal haemodynamic measurements included effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) by radionuclide study using 131I-hippuran and 99mTc, with methods described by Schlegel and Gates, respectively. In addition, effective renal blood flow [ERBF=ERPF/(1-Ht)], filtration fraction (FF=GFR/ERPF) ERPF) and renal vascular resistance (RVR=MBP×80/ERBF) were calculated. Plasma renin activity (PRA), serum aldosterone (ALD) and urinary excretion of sodium (NaU) were evaluated.
At the end of amlodipine administration a significant decrease (P<0.001) in SBP, DBP and MBP from baseline values was observed. A significant decrease (P<0.01) in RVR and significant increases (P<0.05) in ERPF, ERBF and in NaU were also found, without relevant changes in GFR, FF, PRA and ALD.
No significant variation in clinical and renal measurements was observed in the placebo group.
No relevant side effects were observed in either group. In conclusion, amlodipine was effective in lowering blood pressure in mild to moderate hypertension and exerted favourable effects on renal haemodynamics and function.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Man in't Veld AJ (1989) Calcium antagonists in hypertension. Am J Med 86 [Suppl A]: 6–14
Julius S (1988) Amlodipine in hypertension: an overview of the clinical dossier. J Cardiovasc Pharmacol 12 [Suppl 7]: S27-S33
Carter AJ, Gardiner DG, Burges RA (1988) Natriuretic activity of amlodipine, diltiazem and nitrendipine in saline-loaded anesthetized dogs. J Cardiovasc Pharmacol 12 [Suppl 7]: S34-S38
De Brruijn B, Cocco G, Tyler HM et al. (1988) Multicentre placebo-controlled comparison of amlodipine and atenolol in mild to moderate hypertension. J Cardiovasc Pharmacol 12 [Suppl 7]: S107-S109
Loutzenhiser RD, Epstein M, Fischetti F, Horton C (1989) Effects of amlodipine on renal haemodynamics. Am J Cardiol 64: 1221–1281
Ruilope LM, Alcazar LM (1990) Renal effects of calcium entry blockers. Cardiovasc Drugs Ther 4: 979–982
Schmieder RE, Messerli FH, Garavaglia G, Nunez B (1990) Glomerular hyperfiltration indicates early target organ damage in essential hypertension. JAMA 264: 2775–2780
Devereux RB, Alonso DR, Lutax EM (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57: 450–458
Schlegel JU, Haway SA (1976) Individual renal plasma flow determination in 2 minutes. J Urol 111: 282–288
Gates GE (1981) Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc DTPA. Am J Radiol 138: 565–570
Chachati A, Meyers A, Gordon JP, Rigo P (1987) Rapid method for measurement of differential renal function: validation. J Nucl Med 28: 829–836
Scaglione R, Indovina A, Parrinello G, Lipari R, Mulè LG, Ganguzza A, Capuana G, Gallo Stampino C, Licata G (1992) Antihypertensive efficacy and effects of nitrendipine on cardiac and renal haemodynamics in mild to moderate hypertensive patients. Randomized controlled trial versus hydrochlorothiazide. Cardiovasc Drugs Ther 6: 141–146
Licata G, Scaglione R, Guillet C, Capuana G, Parrinello G, Indovina A, Lipari R, Mazzola G, Merlino G (1992) Double-blind controlled study of rilmenidine versus hydrochlorothiazide in mild hypertension: clinical and renal haemodynamic evaluation. J Hum Hypertens 6: 140–146
Reams GP, Hamory A, Lau A, Bauer JH (1988) Effects of nifedipine on renal function in patients with essential hypertension. Hypertension 11: 452–456
Sunderrjan S, Reams G, Bauer JH (1986) Renal effects of diltiazem in primary hypertension. Hypertension 8: 238–242
Zanchetti A, Leonetti G (1987) Discussion on the natriuretic effects of calcium antagonists. J Cardiovasc Pharmacol 10 [Suppl 1]: S161-S164
Romero JC, Rau L, Granger JP, Ruilope LM, Rodicio JL (1987) Multiple effects of calcium entry blockers on renal function in hypertension. Hypertension 10: 140–151
Bauer JH, Reams G (1987) Short- and long-term effects of calcium entry blockers on the kidney. Am J Cardiol 59: 66A-71A
Hartford M, Wendelhag I, Berglund G (1988) Cardiovascular and renal effects of long-term antihypertensive treatment. JAMA 259: 2553–2557
Pettinger WA, Lee HC, Reisch J (1989) Long-term improvement in renal function after short-term strict blood pressure control in hypertensive nephrosclerosis. Hypertension 13: 766–772
De Leeuw PW, Birkenager WH (1983) Renal effects of betablockade in essential hypertension. Eur Heart J 4 [Suppl D]: 13–18
Schlueter WA, Batelle DC (1989) Renal effects of antihypertensive drugs. Drugs 37: 900–925
Anderson S, Rennke HG, Brenner BM (1986) Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77: 1993–2000
Anderson S, Mayer TW, Rennke HG (1985) Control glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76: 612–619
Dworkin LD, Feiner HD, Randazzo J (1986) Glomerular injury in uninephrectomized spontaneously hypertensive rats: a consequence of glomerular capillary hypertension. J Clin Invest 77: 797–809
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Licata, G., Scaglione, R., Ganguzza, A. et al. Effects of amlodipine on renal haemodynamics in mild to moderate hypertensive patients. Eur J Clin Pharmacol 45, 307–311 (1993). https://doi.org/10.1007/BF00265946
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00265946